ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jeffrey M. Piehler
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piehler, J. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Piehler, J. M.
Related Collections
Right arrow Lung - cancer
Right arrowRelated Article

Ann Thorac Surg 2004;78:1206
© 2004 The Society of Thoracic Surgeons

INVITED COMMENTARY

Jeffrey M. Piehler, MD

Department of Cardiothoracic Surgery, University of Kansas Medical Center3901 Rainbow Blvd, Kansas City, KS 66160, USA

The first 20% of the full text of this article appears below.

Acknowledgement of the limitations of current therapy for the large number of patients with locally advanced lung cancer is part of the daily lexicon of general thoracic surgeons. While waiting for the much needed quantum leap in systemic therapy, we must be satisfied with small increments in survival that can sometimes be achieved by careful manipulation of existing therapeutic modalities. Granted, the staggering prevalence of the disease allows even small advances to be impressively magnified in number of lives altered; nevertheless, such epidemiologic consequences are of limited consolation to the individual surgeon who continues to witness far more failures than successes with these patients, usually due to systemic progression of disease.

The trimodality strategy of concomitant chemotherapy and radiation therapy followed by resection is now generally accepted as the preferred approach to . . . [Full Text of this Article]


Related Article

Pulmonary Resection After Curative Intent Radiotherapy (>59 Gy) and Concurrent Chemotherapy in Non–Small-Cell Lung Cancer
Joshua R. Sonett, Mohan Suntharalingam, Martin J. Edelman, Ashish B. Patel, Ziv Gamliel, Austin Doyle, Peter Hausner, and Mark Krasna
Ann. Thorac. Surg. 2004 78: 1200-1205. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.